Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Johnson & Johnson (JNJ:NYSE), powered by AI.
Johnson & Johnson is currently trading at $235.18. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Johnson & Johnson on Alpha Lenz.
Johnson & Johnson's P/E ratio is 21.1.
“Johnson & Johnson trades at a P/E of 21.1 (fair value) with strong ROE of 35.0%. Operating margin of 27.2% indicates strong profitability.”
Ask for details →Johnson & Johnson is a multinational corporation engaged in the research, development, production, and sale of a broad range of healthcare products. Primarily known for its pharmaceuticals, medical devices, and consumer health products, Johnson & Johnson has a significant presence in the global healthcare industry. It develops medications for a variety of fields such as immunology, oncology, neurology, infectious diseases, and vaccines. The company also produces a wide array of medical devices for surgery, orthopedics, and cardiovascular health. In addition to pharmaceuticals, Johnson & Johnson is renowned for its consumer health products, including baby care, skin and hair care, wound care, and over-the-counter pharmaceuticals, with well-recognized brands like Band-Aid, Tylenol, and Neutrogena. Operating globally, the corporation's extensive portfolio and commitment to healthcare innovation make it a pivotal player in the industry, ensuring it remains influential in addressing worldwide health challenges and advancing medical technology.
“Johnson & Johnson trades at a P/E of 21.1 (fair value) with strong ROE of 35.0%. Operating margin of 27.2% indicates strong profitability.”
Ask for details →Johnson & Johnson (ticker: JNJ) is a company listed on NYSE in the Healthcare sector (Drug Manufacturers - General). It has approximately 138,100 employees. Market cap is $566.3B.
The current price is $235.18 with a P/E ratio of 21.13x and P/B of 6.94x.
ROE is 35.03% and operating margin is 27.17%. Annual revenue is $94.2B.